Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06911632 · ClinicalTrials.gov registry record · NA
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
A NA study of Pulmonary Hypertension and Interstitial Lung Disease (ILD), sponsored by Tempus AI.
- Active
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
- 20
- Study locations
NCT06911632: Active NA study of Pulmonary Hypertension and Interstitial Lung Disease (ILD), sponsored by Tempus AI.
NCT06911632 is a NA study of Pulmonary Hypertension and Interstitial Lung Disease (ILD) that is active but no longer recruiting, run by Tempus AI. The registered enrollment target is 1,000 participants, above the 600-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (67% higher). The trial reports 20 study locations across 17 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06911632, a NA study of Pulmonary Hypertension and Interstitial Lung Disease (ILD), is active but no longer recruiting, sponsored by Tempus AI.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
MOMENTOUS is a multi-center, randomized study to prospectively evaluate the performance of an ECG-based AI device to predict whether participants with interstitial lung disease (ILD) are at high risk of undiagnosed pulmonary hypertension.
Primary Outcome
Mean pulmonary artery pressure (mPAP) \> 20 mm Hg and pulmonary vascular resistance (PVR) \> 2 Wood units
Conditions Studied
Interventions
- DEVICE ECG-based AI Device - Results Returned to Investigator
- PROCEDURE Echocardiogram and Right Heart Catheterization
- DEVICE ECG-based AI Device - Results Not Returned to Investigator
Study Locations (20)
Arizona
- Banner University Medical Center - Phoenix
- Dignity Health - St. Joseph's Hospital and Medical Center-Norton Thoracic Institute - Phoenix
Illinois
- Northwestern University - Chicago
- University of Illinois Health - Chicago
Indiana
- Indiana University Health Methodist Hospital - Indianapolis
- Community Health Network - Indianapolis
Alabama
- University of Alabama at Birmingham - Birmingham
Colorado
- National Jewish Health - Denver
Florida
- AdventHealth Orlando - Orlando
Kentucky
- University of Kentucky - Lexington
Louisiana
- Louisiana State University Health Shreveport - Shreveport
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2025-07-23 |
| Est. Completion | 2028-07 |
| Phase | NA |
What the registry record for NCT06911632 still lists
NCT06911632 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 600-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (67% higher).
The record links to 2 conditions, with Pulmonary Hypertension appearing as the primary indexed condition, and to 3 interventions - of which ECG-based AI Device - Results Returned to Investigator is the first listed.
NCT06911632 names 20 study sites across 17 states, led by Arizona, Illinois, Indiana.
Frequently Asked Questions
What is clinical trial NCT06911632 about?
NCT06911632 is a clinical study titled "Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension". MOMENTOUS is a multi-center, randomized study to prospectively evaluate the performance of an ECG-based AI device to predict whether participants with interstitial lung disease (ILD) are at high risk of undiagnosed pulmonary hypertension.
What is the current status of trial NCT06911632?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2025-07-23. Estimated completion is 2028-07.
What conditions does trial NCT06911632 study?
This clinical trial studies the following conditions: Pulmonary Hypertension, Interstitial Lung Disease (ILD).
What interventions are being tested in trial NCT06911632?
The interventions under investigation include: ECG-based AI Device - Results Returned to Investigator (DEVICE), Echocardiogram and Right Heart Catheterization (PROCEDURE), ECG-based AI Device - Results Not Returned to Investigator (DEVICE).
Who is sponsoring clinical trial NCT06911632?
This trial is sponsored by Tempus AI, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06911632 being conducted?
This trial has 20 study locations across Alabama, Arizona, Colorado, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06911632's enrollment target sits among peer trials
1,000 8th of 72 higher than 63 of 72 other Pulmonary Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
RECRUITING · NA
-
Evaluating Infrasonic Hemodynography
RECRUITING · NA
-
Identifying Right Ventricular Dysfunction in COPD Through Right Heart Catheterization, Imaging and Exercise
RECRUITING · NA
-
iTONE Trial (exercIse Training in pulmONary hypertEnsion) Exercise Program for Pediatric PH
RECRUITING · NA
-
Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI